Skip to Content
Morningstar

OrbusNeich Medical Group Holdings Ltd 06929

Morningstar Rating
Unlock
Stock XHKG Rating as of
HKD 3.83 +0.15 (4.08%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Chinese Endovascular Device Maker OrbusNeich Has Global Reach and Growth Potential

Yurou Zheng

OrbusNeich differentiates itself as a specialist global medical device maker, producing percutaneous coronary intervention, or PCI, and percutaneous transluminal angioplasty, or PTA, devices. These are more commonly known as stents and balloons. Minimally invasive procedures such as PCIs are preferred novel treatments when treating cardiovascular diseases. Compared with traditional chest-opening procedures, OrbusNeich’s products are less traumatic and have less hospitalization time. Hence, we believe OrbusNeich can enjoy secular growth for the next five to 10 years.

Read Full Report

Price vs Fair Value

View History
06929 is trading at a 51% discount.
Price
HKD 3.44
Fair Value
HKD 7.76
Uncertainty
Very High
1-Star Price
HKD 95.88
5-Star Price
HKD 8.48
Economic Moat
Pfvrg
Capital Allocation
Fwwkfpjx

Bulls Say, Bears Say

Bulls

Due to the increasing number of cardiovascular diseases, OrbusNeich may grow at an annual compounded rate of high teens for the next five to 10 years.

Bears

Geopolitical tensions escalate such that there may be more tax imposed on OrbusNeich products when sold in the US.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 06929 is a good fit for your portfolio.
Get 7 Days Free

Trading Information

Previous Close Price
HKD 3.68
Day Range
HKD 3.70–3.88
52-Week Range
HKD 3.01–14.82
Bid/Ask
HKD 3.81 / HKD 3.83
Market Cap
HKD 3.17 Bil
Volume/Avg
510,500 / 213,361

Key Statistics

Price/Earnings (Normalized)
8.31
Price/Sales
2.54
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
2.61%
Total Yield
0.21%

Company Profile

OrbusNeich is a China-based global medical device maker of endovascular interventional instruments with global reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich’s largest revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its largest product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
1,249
Website
https://www.orbusneich.com

Competitors

Valuation

View More
Metric
06929
BSX
ABT
Price/Earnings (Normalized)
 8.3135.7424.07
Price/Book Value
 1.065.574.80
Price/Sales
 2.547.334.63
Price/Cash Flow
 9.5932.7519.20
Price/Earnings
06929
BSX
ABT

Financial Strength

Metric
06929
BSX
ABT
Quick Ratio
 8.480.631.16
Current Ratio
 9.771.321.64
Interest Coverage
 291.768.4110.86
Quick Ratio
06929
BSX
ABT

Profitability

Metric
06929
BSX
ABT
Return on Assets (Normalized)
 12.21%8.92%10.63%
Return on Equity (Normalized)
 13.34%16.33%20.87%
Return on Invested Capital (Normalized)
 10.42%11.43%14.81%
Return on Assets
06929
BSX
ABT
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Instruments & Supplies Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncCsyvnnszfHcdj$133.1 Bil
BDX
Becton Dickinson & CoXxpymtljBfnzx$66.9 Bil
ALC
Alcon IncQscrdkvYzfbw$38.9 Bil
RMD
ResMed IncYfkdshmltMjcngr$32.1 Bil
CLPBY
Coloplast A/S ADRKzsxzyggxYfjd$27.9 Bil
WST
West Pharmaceutical Services IncXlhnpllsFdh$26.4 Bil
BAX
Baxter International IncWrslvbscJtrcd$20.4 Bil
HOLX
Hologic IncKxpdpcxPsgwzgg$17.8 Bil
COO
The Cooper Companies IncFflqhmdXdxch$17.7 Bil
TFX
Teleflex IncCjrRqbd$9.7 Bil

Sponsor Center